Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Denise Lawlor"'
Autor:
Aashna, Patel, Roshni, Kalachand, Steven, Busschots, Ben, Doherty, Evangelos, Kapros, Denise, Lawlor, Neville, Hall, Britta K, Stordal
Publikováno v:
Cochrane Database of Systematic Reviews. 2022
Ovarian cancer is the seventh most frequent cancer diagnosis worldwide, and the eighth leading cause of cancer mortality. Epithelial ovarian cancer is the most common kind, accounting for 90% of cases. First-line therapy for women with epithelial ova
Autor:
Uwe Kuhn, Jeanette Muller, Sallam Al Hassoon, Martin P. Barr, Denise Lawlor, Eyad Amireh, Daniela Infante, Peadar MacGabhann, Maxim Al Ashhab, Khetam Hamza, Mohammed Jasser, Kenneth J. O'Byrne, Lina Souan, Kathy Gately, Maher A. Sughayer
Publikováno v:
Biopreservation and Biobanking. 12:3-12
Research studies aimed at advancing cancer prevention, diagnosis, and treatment depend on a number of key resources, including a ready supply of high-quality annotated biospecimens from diverse ethnic populations that can be used to test new drugs, a
Autor:
Denise Lawlor, Sue Crosby
Publikováno v:
Women and Birth. 31:S14-S15
Autor:
Ben, Doherty, Denise, Lawlor, Jean-Pierre, Gillet, Michael, Gottesman, John J, O'Leary, Britta, Stordal
Publikováno v:
Anticancer research. 34(1)
KB-8-5-11 cells are a drug-resistant cervical cell model that overexpresses ABCB1 (P-glycoprotein). KB-8-5-11 has become sensitive to non-ABCB1 substrate cisplatin. Understanding the mechanism of collateral sensitivity to cisplatin may lead to biomar
Autor:
Bryan T. Hennessy, Denise Lawlor, Patricia Martin, Britta K. Stordal, Steven Busschots, Julien Thery, John J. O'Leary
Publikováno v:
Journal of pharmaceutical sciences. 103(6)
The cytotoxicity of PARP inhibitors olaparib, veliparib, and CEP-8983 were investigated in two P-glycoprotein (P-gp) overexpressing drug-resistant cell models (IGROVCDDP and KB-8-5-11). IGROVCDDP and KB-8-5-11 were both resistant to olaparib and resi